Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Natco Pharma Ltd.
BSE
Price on BSE
13 May,15:43 LIVE
1,172.90
-8.80
(-0.74%)
© 2026 Rediff.com
Volume :
34,877.00
Prev Close :
1,181.70
Day's H/L (Rs.) :
1,199.10 - 1,166.80
52wk H/L (Rs.) :
1,226.10 - 789.30
Mkt Cap (Rs. Cr) :
21,006.64
NSE
Price on NSE
13 May,15:59 LIVE
1,171.90
-10.00
(-0.85%)
© 2026 Rediff.com
Volume :
372,471.00
Prev Close :
1,181.90
Day's H/L (Rs.) :
1,199.90 - 1,165.00
52wk H/L (Rs.) :
1,226.80 - 789.00
Mkt Cap (Rs. Cr) :
0.00
View more
Market News
Semaglutide Ruling Sparks Generic Pharma Boom
Rediff.com
24 Mar 2026
Abbott Bets On Semaglutide Boom
Rediff.com
28 Feb 2026
Report Card - Natco Pharma Ltd.
PE Ratios
11.43
EPS (Rs.)
103.37
Sales (Rs. Cr)
528.80
Face Value (Rs.)
2
Net Profit Margin(%)
45.19
Last Bonus
-
Last Dividend(%)
75
Return on Average Equity
25.23
News for Natco Pharma Ltd.
Generic Semaglutide Launched in India by Eris, Natco
Eris & Natco launch generic Semaglutide (Ozempic, Wegovy) in India after patent expiry. Affordable diabetes & weight management options available.
Mar 20, 2026 16:23
Women''s Hygiene Market: Pee Safe Success Story
Pee Safe''s success highlights the growth potential in the women''s hygiene market in India. Venture Catalysts recognized this early on.
Mar 17, 2026 13:04
NATCO Pharma Launches Generic Cancer Drug in US
NATCO Pharma launches generic Pomalidomide capsules for blood cancer treatment in the US with Breckenridge Pharmaceutical.
Mar 03, 2026 13:34
Eris & Natco Partner on Semaglutide in India
Eris Lifesciences partners with Natco Pharma to commercialise semaglutide in India for diabetes and weight management.
Feb 24, 2026 11:15
Natco Pharma Q3 Net Profit Up 14% YoY
Natco Pharma reports Q3 net profit of Rs 151 crore, up 14% YoY. Board declares dividend, approves chairman reappointment and Chile subsidiary.
Feb 12, 2026 18:27
More News for Natco Pharma Ltd. »
News for Pharmaceuticals and health care
Airtel Q4 Net Profit Drops 33.5% to Rs 7,325 Crore
Bharti Airtel reports a 33.5% drop in Q4 net profit to Rs 7,325 crore. Revenue crosses Rs 2 lakh crore, driven by customer growth and ARPU.
May 13, 2026 20:44
Remove Cotton Import Duty: AEPC Asks Govt
AEPC urges government to remove 11% cotton import duty to help textile industry compete globally and boost exports amid rising costs.
May 13, 2026 20:42
Metropolis Healthcare Q4 Profit Rises
Metropolis Healthcare reports 74% rise in Q4 profit to Rs 50.96 cr. Revenue up 23% YoY. Dividend of Re 1 per share approved.
May 13, 2026 20:35
Crompton Greaves: Rs 531 Cr Net Loss in Q4
Crompton Greaves Consumer Electricals reports Rs 531.07 crore net loss in Q4 due to Butterfly subsidiary impairment.
May 13, 2026 20:30
RBI Eases Outward Remittance Rules for Non-Banks
RBI removes prior approval for non-banks to facilitate outward remittances via banks. AD banks now responsible for FEMA, KYC compliance.
May 13, 2026 20:25
More News »
Top News
Iran Welcomes India's Peace Initiative in West Asia
Iran welcomes India's peace efforts in West Asia, addresses BRICS consensus challenges, and discusses Strait of Hormuz passage.
May 13, 2026 20:51
Gujarat CM Cuts Convoy Size, Minister Cancels US Visit
Gujarat CM and ministers reduce convoy size, Deputy CM cancels US visit amid PM Modi's austerity call due to West Asia crisis.
May 13, 2026 20:49
Airtel Q4 Net Profit Drops 33.5% to Rs 7,325 Crore
Bharti Airtel reports a 33.5% drop in Q4 net profit to Rs 7,325 crore. Revenue crosses Rs 2 lakh crore, driven by customer growth and ARPU.
May 13, 2026 20:44
Remove Cotton Import Duty: AEPC Asks Govt
AEPC urges government to remove 11% cotton import duty to help textile industry compete globally and boost exports amid rising costs.
May 13, 2026 20:42
Metropolis Healthcare Q4 Profit Rises
Metropolis Healthcare reports 74% rise in Q4 profit to Rs 50.96 cr. Revenue up 23% YoY. Dividend of Re 1 per share approved.
May 13, 2026 20:35
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist